In SPHINX, the spontaneous clearance of HC viruses will be investigated using x-Omics technologies. For this purpose, (1) plasma profiles are created, (2) the HCV-specific cellular immune responses ar
Development of universal test methods for the reliability of flexible microimplants and their encapsulation. In the APreMedI project, standardized test methods for the validation of flexible active im
The M-Era.NET project interBATT combines unique and complementary expertise from three applied research institutions (NMI and DLR in Germany and LIST in Luxembourg) and two industrial partners (Custom
Biomarker Dr. Nicole Schneiderhan-Marra Head of Pharma & Biotech +49 7121 51530-815 E-Mail CV Indicators for diagnosis and therapy Quantitative detection of a variety of biomarkers with simultaneous h
Collagen-based biomaterials and biochemical functionalization of collagen Dr. Xin Xiong Group Leader Biofunctionalized Surfaces +49 7121 51530-413 E-Mail CV Our innovative biomaterials research and ad
Biomarkers and Immunoassays Dr. Jens Göpfert Group Leader Applied Biomarkers and Immunoassays +49 7121 51530-471 E-Mail CV Analysis of biological changes with precise, reliable and highly sensitive an
Dr. Peter D. Jones Group Leader Biomedical Micro and Nano Engineering +49 7121 51530-800 E-Mail anzeigen Lab-on-chip (LoC) systems have been developed and applied in academic research for more than a
Production of Solid State Nanopores Dr. Peter D. Jones Group Leader Biomedical Micro and Nano Engineering +49 7121 51530-800 E-Mail anzeigen The research field of solid-state nanopores and nanofluidic
Biomarker and Assay Development Dr. Nicole Schneiderhan-Marra Head of Pharma & Biotech +49 7121 51530-815 E-Mail anzeigen Dr. Markus Templin Group Leader Assay Development +49 7121 51530-828 E-Mail an
Microtumor Models Dr. Christian Schmees Group Leader Tumor Biology +49 7121 51530-881 E-Mail anzeigen Patient-derived microtumors for drug development and compound efficacy testing By developing novel
